Indivior PLC (INDV)
NASDAQ: INDV · Real-Time Price · USD
36.05
+0.84 (2.39%)
Dec 22, 2025, 1:30 PM EST - Market open
Indivior Market Cap
Indivior has a market cap or net worth of $4.5 billion as of December 22, 2025. Its market cap has increased by 215.12% in one year.
Market Cap
4.50B
Enterprise Value
4.31B
1-Year Change
215.12%
Ranking
Category
Stock Price
$36.05
Market Cap Chart
Since December 29, 2014, Indivior's market cap has increased from $1.53B to $4.50B, an increase of 194.07%. That is a compound annual growth rate of 10.32%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 19, 2025 | 4.40B | 183.00% |
| Dec 31, 2024 | 1.55B | -25.50% |
| Dec 29, 2023 | 2.09B | -29.77% |
| Dec 29, 2022 | 2.97B | 22.55% |
| Dec 31, 2021 | 2.42B | 125.44% |
| Dec 31, 2020 | 1.07B | 182.79% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 953.98B |
| Johnson & Johnson | 499.13B |
| AbbVie | 401.07B |
| UnitedHealth Group | 295.76B |
| AstraZeneca | 283.55B |
| Novartis AG | 261.76B |
| Merck & Co. | 256.00B |
| Abbott Laboratories | 219.55B |